Morgan Stanley’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$98.3M Buy
4,347,748
+1,862,938
+75% +$41.8M 0.01% 1579
2026
Q1
$56.1M Sell
2,484,810
-455,029
-15% -$10.5M ﹤0.01% 1985
2025
Q4
$70M Buy
2,939,839
+942,497
+47% +$23.4M ﹤0.01% 1759
2025
Q3
$52.6M Sell
1,997,342
-371,747
-16% -$9.56M ﹤0.01% 1966
2025
Q2
$67.7M Buy
2,369,089
+1,318,405
+125% +$35.4M ﹤0.01% 1643
2025
Q1
$26.2M Buy
1,050,684
+15,725
+2% +$374K ﹤0.01% 2421
2024
Q4
$23.4M Buy
1,034,959
+3,057
+0.3% +$66.4K ﹤0.01% 2601
2024
Q3
$22M Buy
1,031,902
+53,322
+5% +$1.05M ﹤0.01% 2708
2024
Q2
$18.7M Sell
978,580
-17,126
-2% -$349K ﹤0.01% 2741
2024
Q1
$19.2M Buy
995,706
+44,207
+5% +$876K ﹤0.01% 2746
2023
Q4
$19.8M Sell
951,499
-89,948
-9% -$1.73M ﹤0.01% 2697
2023
Q3
$22.4M Buy
1,041,447
+36,820
+4% +$894K ﹤0.01% 2329
2023
Q2
$24M Sell
1,004,627
-43,724
-4% -$1M ﹤0.01% 2284
2023
Q1
$22.3M Buy
1,048,351
+90,720
+9% +$1.74M ﹤0.01% 2308
2022
Q4
$15.6M Sell
957,631
-96,486
-9% -$1.43M ﹤0.01% 2589
2022
Q3
$14.8M Buy
1,054,117
+610,550
+138% +$11.5M ﹤0.01% 2538
2022
Q2
$11.1M Buy
443,567
+253,592
+133% +$7.58M ﹤0.01% 2974
2022
Q1
$6.4M Sell
189,975
-143,224
-43% -$4.71M ﹤0.01% 3417
2021
Q4
$10.8M Sell
333,199
-174,317
-34% -$5.74M ﹤0.01% 2871
2021
Q3
$17.7M Sell
507,516
-142,945
-22% -$5.58M ﹤0.01% 2216
2021
Q2
$27M Sell
650,461
-149,863
-19% -$5.99M ﹤0.01% 1837
2021
Q1
$29.5M Sell
800,324
-661,466
-45% -$25M ﹤0.01% 1570
2020
Q4
$60.8M Sell
1,461,790
-155,305
-10% -$6.47M 0.01% 953
2020
Q3
$68.7M Sell
1,617,095
-50,316
-3% -$2.17M 0.01% 755
2020
Q2
$72.2M Buy
1,667,411
+253,773
+18% +$10M 0.02% 674
2020
Q1
$46.4M Sell
1,413,638
-547,252
-28% -$20.3M 0.01% 770
2019
Q4
$72.2M Buy
1,960,890
+459,548
+31% +$16.3M 0.02% 755
2019
Q3
$50.4M Sell
1,501,342
-349,454
-19% -$12.4M 0.01% 850
2019
Q2
$72.7M Buy
1,850,796
+643,494
+53% +$25.5M 0.02% 678
2019
Q1
$48.9M Sell
1,207,302
-280,691
-19% -$10.5M 0.01% 847
2018
Q4
$48.2M Buy
1,487,993
+390,902
+36% +$15.8M 0.01% 835
2018
Q3
$56.4M Sell
1,097,091
-147,819
-12% -$7.4M 0.01% 887
2018
Q2
$62.7M Sell
1,244,910
-166,877
-12% -$8.46M 0.02% 793
2018
Q1
$72.1M Buy
1,411,787
+185,003
+15% +$9.87M 0.02% 734
2017
Q4
$64.5M Buy
1,226,784
+304,238
+33% +$15.1M 0.02% 776
2017
Q3
$45.1M Buy
922,546
+220,713
+31% +$10.5M 0.01% 962
2017
Q2
$33.9M Sell
701,833
-9,266
-1% -$427K 0.01% 1138
2017
Q1
$30M Sell
711,099
-5,940
-0.8% -$246K 0.01% 1241
2016
Q4
$30.3M Buy
717,039
+43,143
+6% +$1.76M 0.01% 1195
2016
Q3
$29.5M Sell
673,896
-24,541
-4% -$1.1M 0.01% 1171
2016
Q2
$30.4M Buy
698,437
+436
+0.1% +$18.8K 0.01% 1109
2016
Q1
$30.8M Buy
698,001
+12,663
+2% +$536K 0.01% 1034
2015
Q4
$28.7M Buy
685,338
+116,653
+21% +$4.91M 0.01% 1148
2015
Q3
$22.2M Buy
568,685
+64,095
+13% +$2.61M 0.01% 1295
2015
Q2
$21M Buy
504,590
+93,440
+23% +$3.99M 0.01% 1456
2015
Q1
$17M Buy
411,150
+76,064
+23% +$2.94M 0.01% 1587
2014
Q4
$12.4M Buy
335,086
+141,947
+73% +$5.12M ﹤0.01% 1866
2014
Q3
$6.7M Buy
193,139
+57,032
+42% +$1.97M ﹤0.01% 2380
2014
Q2
$4.56M Buy
136,107
+75,101
+123% +$2.5M ﹤0.01% 2748
2014
Q1
$2.13M Sell
61,006
-10,455
-15% -$366K ﹤0.01% 3363
2013
Q4
$2.54M Sell
71,461
-5,161
-7% -$173K ﹤0.01% 3199
2013
Q3
$2.48M Sell
76,622
-45,994
-38% -$1.5M ﹤0.01% 3052
2013
Q2
$4.32M Buy
+122,616
New +$4.26M ﹤0.01% 2468

Other funds holding FMS

Morgan Stanley's FMS Position: Q2 2026 in Review

Morgan Stanley increased its Fresenius Medical Care (FMS) stake by 75% in Q2 2026, buying an estimated $41.8M and bringing the position to 4,347,748 shares worth $98.3M. The position accounts for 0.01% of the portfolio, ranked #1579.

Morgan Stanley first reported a position in FMS in Q2 2013 and has held it in 53 quarters since. 233 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Morgan Stanley held 4,347,748 shares of Fresenius Medical Care worth $98.3M as of Q2 2026.
  • Morgan Stanley bought 1,862,938 Fresenius Medical Care shares in Q2 2026, an estimated $41.8M.
  • Fresenius Medical Care made up 0.01% of Morgan Stanley's portfolio in Q2 2026, its #1579 holding.
  • Morgan Stanley first reported a position in Fresenius Medical Care in Q2 2013 and has held it in 53 quarters since.
  • 233 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.